Crick spin‑out ALTx will target cancer cell immortality

  Founded in late 2024, ALTx Therapeutics has come out of stealth mode with plans to develop therapies to target the alternative lengthening of telomeres (ALT) pathway in cancer cells. Telomeres are sections at the end of chromosomes that get shorter as cells divide and as we age…. Source link

AI Military Startup Anduril Near $28 Billion Valuation

The Rise of Autonomous Weapons: A New Era in Warfare Table of Contents The Rise of Autonomous Weapons: A New Era in Warfare The allure of Autonomy Ethical Crossroads: Navigating the Moral Maze Shaping the Future: Responsible Development and Deployment FAQs The battlefield of the future is rapidly evolving, driven by advancements in artificial intelligence … Read more

Fashion’s Most Anticipated M&A Hot Spots in 2025

Fashion dealmaking is back in full swing. Lower interest rates and the prospect of a business-friendly Trump administration have unleashed a torrent of deals. While most have been small, it raises hopes that buyers will next set their sights on big start-ups and heritage brands long rumoured to be in the market. Kapital, True Religion … Read more

How Smartphones Powered The AI boom In 2024

The generative AI boom continued at pace in 2024, with smartphones becoming a key battleground for the technology’s development as Samsung, Google and Apple all introduced new AI tools to their devices. Many commentators and the tech firms themselves have said a big hurdle when it comes to generative AI features is getting them in … Read more